• Drug: sildenafil
  • Manufacturer: misc

  • Route of Administration: Oral

  • Site of Care: Outpatient
  • Approved Indication:

    • to improve exercise ability and delay clinical worsening adult patients with pulmonary arterial hypertension (PAH WHO group 1)
    • to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise in pediatric patients 1 to 17 years old with pulmonary arterial hypertension (PAH WHO group 1)

  • Disease: pulmonary arterial hypertension

  • Therapeutic Area: Pulmonary

  • Enrollment Form Link: N/A

  • Phone Number: N/A

  • Fax Number: N/A

  • Product Website: N/A